Iobitridol
- Generic Name
- Iobitridol
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C20H28I3N3O9
- CAS Number
- 136949-58-1
- Unique Ingredient Identifier
- 182ECH14UH
- Background
Iobitridol has been used in trials studying the diagnostic of Diagnostic Imaging, Coronary Artery Disease, Type 2 Diabetes Mellitus, and Coronary Atherosclerosis.
- Indication
用于Ｘ线尿路静脉造影、动脉造影、头颅和全身计算机断层扫描（ＣＴ）、静脉血管数字减影。
- Associated Conditions
- -
- Associated Therapies
- -
Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-12-07
- Last Posted Date
- 2015-12-16
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 468
- Registration Number
- NCT01255722
- Locations
- 🇫🇷
CHU Rouen - Hopital Charles Nicolle, Rouen, France
🇫🇷La Timone Adultes, Marseille, France
🇫🇷Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France
Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
Phase 4
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-12-06
- Last Posted Date
- 2019-05-31
- Lead Sponsor
- Guerbet
- Target Recruit Count
- 351
- Registration Number
- NCT01254552
- Locations
- 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-09-29
- Last Posted Date
- 2008-11-26
- Lead Sponsor
- Guerbet
- Registration Number
- NCT00382317
- Locations
- 🇦🇹
AKH, Vienna, Austria
🇫🇷CHU Charles Nicolle, Rouen, France
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath